Last reviewed · How we verify
NCT03132727: Larynx MRI
Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer
trial testing Pharyngo laryngeal MRI in Hypopharyngeal Carcinoma in 73 participants. Completed in 22 November 2019.
22 November 2019
Quick facts
| Lead sponsor | Hospices Civils de Lyon |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 73 |
| Start date | 23 March 2017 |
| Primary completion | 22 November 2019 |
| Estimated completion | 22 November 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- Pharyngo laryngeal MRI
Conditions studied
- Hypopharyngeal Carcinoma — all drugs for Hypopharyngeal Carcinoma →
- Laryngeal Carcinoma — all drugs for Laryngeal Carcinoma →
Sponsor
Hospices Civils de Lyon — full company profile →
Who can join
18 and older, any sex, with Hypopharyngeal Carcinoma or Laryngeal Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine if MRI can detect preoperative invasion of cartilage by laryngeal and hypopharyngeal carcinoma, and to compare it to CT imaging and histopathology in excised larynges and/or hypopharynges.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03132727
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypopharyngeal Carcinoma
Currently open trials in the same condition.
- NCT07248956 — Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma · Phase 2 · recruiting
- NCT06761937 — Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients · Phase 1 · recruiting
- NCT07295561 — Salvage Surgery in Recurrent Hypopharyngeal Carcinoma: an Observational Single-institutional Study From 1998 · active not recruiting
- NCT05075980 — Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · Phase 2 · active not recruiting
Other Hospices Civils de Lyon trials
Trials by the same sponsor.
- NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
- NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
- NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
- NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
- NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03132727 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
- Last refreshed: 3 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03132727.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing